Global ELISA Analyzers Market Report 2023-2028 Including Competitive Analysis of Thermo Fisher Scientific, Abcam, Bio-Rad Labs, Merck, F. Hoffmann-La Roche, Danaher, BioTech, Agilent, QIAGEN, and PerkinElmer

dublin, October 27, 2023 /PRNewswire/ — The “ELISA Analyzer Market – Global Industry Size, Share, Trends, Competition, Opportunities and Forecast, 2018-2028” report has been added to Dedication.

research and market signsresearch and market signs

research and market signs

The ELISA Analyzer Market is expected to grow at an impressive CAGR during the forecast period 2024-2028

This can be attributed to factors such as the increasing demand for effective tests to diagnose the prevalence of infectious diseases and the growing demand for technologically advanced disease detection instruments.

Enzyme-linked immunosorbent assay (ELISA) is a laboratory test used to detect antibodies in the blood. ELISA is based on the principle of interaction between antibodies and antigens and is therefore used for disease diagnosis. Analyzers are automated instruments that perform different analytical steps and provide accurate and repeatable results.

In addition, the rising incidence of HIV, hepatitis, cancer, etc., and the increasing involvement of ELISA analyzers in research and development of immunology and drug development are driving the market demand for ELISA analyzers, thereby supporting market growth, which is expected to grow during the forecast period Push it within.

Rising prevalence of infectious diseases

The increasing prevalence of diseases among the population is driving the demand for ELISA analyzers in the market. The increasing prevalence of infectious diseases worldwide has caused significant health concerns for people around the world.

For example, according to the World Health Organization, 296 million people were infected with hepatitis B in 2019, with about 1.5 million new infections every year. Likewise, according to the World Health Organization, the global dengue disease burden has increased, with approximately 3.1 million cases observed, of which more than 25,000 are considered severe cases.

With the rapid increase in infectious diseases such as cancer, hepatitis, HIV, etc., the direct demand for diagnostics is surging, thus driving the market over the forecast period, thus contributing to the market growth.

Growing demand for technologically advanced tools in the field of immunization

Accuracy and rapid analysis of biochemical and immunological parameter maintenance are important requirements for the analysis of immunological test results. The analyzer is designed to ensure ideal performance of the assay, such as maintaining sensitivity, low background noise and fast reproducibility.

Additionally, ELISA analyzers such as the Open Systems Autoanalyzer come with pre-programmed test menus and simple guides that help save installation and provide user convenience.For example, in May 2022Molecular Devices, LLC., a leading provider of high-performance life science solutions, introduces automated work cells for ELISA workflows.

The company introduces five new, off-the-shelf work cells for enzyme-linked immunosorbent assay (ELISA) workflows that offer automation qualities such as increased walk-away time and throughput, and less labor-intensive use in large samples Duplication of efforts is expected to lead to market growth in the coming years.

The growing need to measure enzyme activity

Measurement of enzyme activity and detection of soluble proteins, cytokines, and other protein bodies are driving the market demand for ELISA analyzers. Furthermore, the increase in allergy cases has led to the need for diagnostic techniques such as ELISA. ELISA is a diagnostic technique widely used to detect food allergies.

In addition, the indirect IgE-ELISA method is frequently used to detect allergen-specific IgE in serum samples due to its simplicity and low cost compared with other automated systems.For example, in July 2018Dynex Technologies announces global partnership with ZEUS Scientific.

Market demand for ELISA analyzers has emerged with rising sales and increasing demand for ELISA test kits during COVID-19, which is expected to boost the ELISA analyzer market during the forecast period.

recent developments

ELISA is used to quantify antibody titers and is further used to assess immunogenicity during vaccine development. Therefore, there is an increasing demand for ELISA analyzers from several companies engaged in vaccine development. For example, leading pharmaceutical company Sanofi Incorporation is developing 10 vaccine candidates, according to the latest update from its Q2 2022 earnings conference. July 2022.

competitive landscape

Company Profiles: Detailed analysis of major players in the ELISA Analyzer market.

Reporting scope

ELISA Analyzer Market, By Type:

ELISA Analyzer Market, By Mode:

ELISA Analyzer Market by Application:

  • Immunology

  • vaccine development

  • drug monitoring

  • others

ELISA Analyzer Market, By End User:

ELISA Analyzer Market by Region:

  • North America

  • Europe

  • Asia Pacific

  • middle East & Africa

  • South America

For more information about this report, please visit

About is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.

Media contact information:

Research and Market
Laura WoodSenior Manager

Eastern time office hours please call +1-917-300-0470
US/Canada Toll Free +1-800-526-8630
For GMT office hours please call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the U.S.): +353-1-481-1716




View original content: rad-labs-merck-f-hoffmann-la-roche-danaher-biotech-agilent-qiagen–perkinelmer-301969959.html

Source: Research & Markets

Source link

Leave a Comment